Primary aldosteronism: An update on screening, diagnosis and treatment

Journal of Hypertension

Volumn 26, Issue 8, 2008, Pages 1709-1711

  Rossi, Gian Paolo ^a   Pessina, Achille Cesare ^a   Heagerty, Anthony M ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADRENAL HYPERPLASIA; BLOOD PRESSURE; CARDIOVASCULAR RISK; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; LETTER; METABOLIC SYNDROME X; PREVALENCE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 66149119376     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328306a0b8     Document Type: Letter

References (14)

1. Rossi GP, Bolognesi M, Rizzoni D, Seccia TM, Piva A, Porteri E, et al. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension 2008; 51:1366-1371.
2. Rossi GP, Sechi LA, Giacchetti G, Ronconi V, Strazzullo P, Funder JW. Primary aldosteronism: cardiovascular, renal and metabolic implications. Trends Endocrinol Metab 2008; 19:88-90.
3. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125. hypertensive patients. J Am Coll Cardiol 2006; 48:2293-2300.
4. Olivieri O, Ciacciarelli A, Signorelli D, Pizzolo F, Guarini P, Pavan C, et al. Aldosterone to renin ratio in a primary care setting: the Bussolengo study. J Clin Endocrinol Metab 2004; 89:4221-4226.
5. Idiopathic aldosteronism: a diagnostic artifact? Lancet 1979; 2:1221-1222.
6. Rossi GP, Sacchetto A, Chiesura-Corona M, De Toni R, Gallina M, Feltrin GP, Pessina AC. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104. consecutive cases. J Clin Endocrinol Metab 2001; 86:1083-1090.
7. Rossi GP, Pitter G, Bernante P, Motta R, Feltrin G, Miotto D. Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess at baseline and after adrenocorticotropic hormone (ACTH) stimulation. J Hypertens 2008; 26:989-997.
8. Young WF Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 2007; 356:601-610.
9. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, et al. A survey on adrenal incidentaloma in Italy. Study Group on adrenal tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 2000; 85:637-644.
10. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005; 45:1243-1248.
11. Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Catena C. Long-term renal outcomes in patients with primary aldosteronism. JAMA 2006; 295:2638-2645.
12. Bravo EL, Dustan HP, Tarazi RC. Spironolactone as a nonspecific treatment for primary aldosteronism. Circulation 1973; XLVIII:491-498.
13. Hood SJ, Taylor KP, Ashby MJ, Brown MJ. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio. Circulation 2007; 116:268-275.
14. Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, et al. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 2007; 50:424-431.